aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
InsightRX, founded with a mission to revolutionize personalized medicine, leverages quantitative pharmacology and machine learning to optimize patient treatment and dosing decisions. The company offers a suite of clinical decision support tools designed to provide real-time, individualized treatment insights at the point-of-care. Their platform supports healthcare providers and biopharma companies by delivering precision dosing, real-time clinical analytics, and model-informed precision dosing across various therapeutic areas, including infectious diseases and bone marrow transplants.
Notable figures affiliated with InsightRX include leading experts in pharmacology and data science. The company has secured investments from prominent venture capital firms specializing in healthcare technology. Key achievements include the successful integration of their platform in numerous clinical settings, demonstrating improved patient outcomes and treatment efficacy. InsightRX's impact is evident in its ability to enhance personalized medicine, making significant strides in the field of precision dosing and individualized patient care.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Pharmacology Software
Technology
Analytics, Machine Learning
Tags
Healthtech, SaaS
Model Types
Platform, Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Global
When was InsightRX founded?
InsightRX was founded in 2015.
Where is InsightRX’s headquarters located?
InsightRX’s headquarters is located in San Francisco, CA, US.
When was InsightRX’s last funding round?
InsightRX’s most recent funding round was for $10M (USD) in September 2019.
How many employees does InsightRX have?
InsightRX has 30 employees as of Feb 5, 2024.
How much has InsightRX raised to-date?
As of July 05, 2023, InsightRX has raised a total of $12.8M (USD) since Sep 19, 2019.
Add Comparison
Total Raised to Date
$12.8M
USD
Last Update Sep 19, 2019
Last Deal Details
$10M
USD
Sep 19, 2019
Series A
Total Employees Over Time
30
As of Feb 2024
InsightRX Address
San Francisco,
California
94115
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts